Lefèvre J P, Johansson L, Kowalski A. "一种的合成方法" [P]. European Patent, EP 3922148 A1, 2021-09-02.
发明人王建平,韩伟,马晓峰. "Method for the Synthesis of 5-(5-Nitrofuran-2-yl)-1,3,4-oxadiazol-2(3H)-one" [P]. 中国发明专利, 专利号 CN 113682993 B, 授权公告日 2022-04-02.
Brown S R, Klinger H, Williams B T. "A Process for Preparing High-Purity 5-(5-Nitrofuran-2-yl)-1,3,4-oxadiazol-2(3H)-one" [P]. US Patent, US 11062585 B2, 2017-06-27.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Food Chem., 2016, 1591, 8254-8267.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2021, 1076, (9), 34-41.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 5-(5-Nitrofuran-2-yl)-1,3,4-oxadiazol-2(3H)-one Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2011, 1706, (8), 9221-9251.